Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Blog Update

#5 Newsletter – JP Jenkins

Fifth Edition

This month we announced another new client (Lexington Gold Warrants), saw the announcement of Superdry PLC joining JPJ and lots of celebratory drinks / awards. Hoorah!

We are delighted to announce the following new admissions to JP Jenkins:

Lexington Gold (JPJ: LEXW):

LEX announces its Warrants (https://lnkd.in/dCnT99cx) have been admitted to trade on JP Jenkins securities matching venue.Lexington Gold, the gold exploration and development company with projects in South Africa and the USA, is pleased to announce that the Company’s existing unlisted 10 pence warrants expiring on 20 July 2026 (the “2026 Warrants”).

Ed Nealon, Lexington Gold’s Non-Executive Chairman, commented:”We are delighted to announce that the warrants issued as part of our July 2023 fundraise will now be capable of being traded on JP Jenkins’ platform. This facility provides our warrant holders with an efficient and accessible venue to potentially trade their securities. The JP Jenkins platform provides transparency and convenience such that our warrant holders can trade with confidence.”

To learn more, read the full RNS below:https://lnkd.in/dCnT99cx

Issuer news – Check out the latest updates and news from our clients:

Cafédirect PLC (JPJ: CDR):

Cafedirect released an announcement this week that shares can be bought and sold on JP Jenkins. They have gone live on our venue and the shares are tradable electronically, with CREST settlement. To see the full post, click here: https://lnkd.in/eGBSdQ8g

e-therapeutics PLC (JPJ: ETX):

e-therapeutics PLC released their audited results for the year ended 31 January 2024 and provided an update on recent pipeline progress.

“The 2023/24 financial year was an important time for e-therapeutics, marking the beginning of a period of effective execution in advancing our therapeutic pipeline. During the year we delivered solid pipeline progress, generating positive preclinical proof-of-concept data for four GalOmic™ RNAi assets discovered in-house.” commented Ali Mortazavi, Chief Executive Officer

Post period operational highlights:

  • Successful fundraise of £28.9 million announced in April 2024 by way of a subscription by funds managed by M&G Investment Management Limited and Richard Griffiths, both existing shareholders of the Company.
  • Completed cancellation of admission of our Ordinary Shares to trading on AIM as of 9 May 2024.
  • Strengthened the Board of Directors with the appointment of Lord David Prior as Chair, as of 23 May 2024.

Please find the full results below:https://www.etherapeutics.co.uk/news-and-media/press-releases/e-therapeutics-announces-pipeline-updates-and-final-year-results-year-end-january-2024/

Thrive Renewables PLC (JPJ: THRV):

Our client Thrive Renewables has just released their 2023 Annual Results. They run regular monthly auctions on JPJ, transacting every month and providing shareholders with pivotal liquidity and reporting.

Please see the full report below: https://www.thriverenewables.co.uk/news/2024/05/thrive-announces-13-6-million-operating-profit-for-2023-with-12-3-million-of-capital-allocated-to-build-new-clean-energy-projects

Sportech (JPJ: SPO):

One of our clients, Sportech (JPJ:SPO) released their FY 2023 Pre-Results Announcement, with the Full Annual Results coming on the 5th July 2024. Sportech, an international betting and hospitality business is pleased to announce a pre-close trading update in respect of the financial year ended 31 December 2023 (‘FY 2023’).

Full release below:https://lnkd.in/dAEdFQwR

Carlisle Support Services (JPJ: CSS):

Our client Carlisle Support Services enjoyed their latest event this month – Rail Safety Week! Carlisle Support Services is a leading supplier of outsourced workforce solutions to chosen niche markets. They provide Security, Cleaning, Events and Retail Merchandising services across the UK and Ireland. Carlisle shares are trading on JP Jenkins, if you are looking to sell or buy shares please get in touch with your broker.

Liquidity Junction

This month was the JP Jenkins Liquidity Junction Summer Drinks! Bringing together the advisors, lawyers, accountants, registrars and many more great companies we work with to support and help our clients. Lovely to see everyone and thank you for all who attended – we look forward to seeing you at our next event 🥂

EISA Awards

The JP Jenkins team enjoyed the EISA Awards 2024 this year. Congratulations to all those shortlisted and those who won. Our team thoroughly enjoyed the drinks on the terrace of the House of Lords tonight. We were nominated as Best Newcomer (InfinitX) post our acquisition.

CISI events:

Exciting times ahead for private asset trading! At our recent webinar with CISI we explored recent innovations, regulatory changes, and the future of private markets. From electronic connections for UK brokers to the evolving market infrastructure.

Great to attend and our CEO Mike McCudden enjoyed being one of the main speakers alongside Colin Anderson. If you missed it, watch it on-demand via CISI TV next week if you are a member here: https://lnkd.in/e5eENn6E

As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com

Learning 101 with  JP Jenkins – Check out our latest videos here on:

Who is JP Jenkins?

Why do companies join?

How to trade?

Have Any Questions?

Let us help you

Want to keep up to date with our companies?

Subscribe to our newsletter and receive latest information on your favourite companies and JP Jenkins news.